ヨーロッパのウイルスベクター精製市場 – 業界動向と2028年までの予測

Customize Your Report レポートをカスタマイズする Buy Now 今すぐ購入 Free Sample Report 無料サンプルレポート
Home Healthcare ヨーロッパのウイルスベクター精製市場
Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

ヨーロッパのウイルスベクター精製市場 – 業界動向と2028年までの予測

  • Healthcare
  • Published Report
  • May 2021
  • Europe
  • 350 ページ
  • テーブル数: 227
  • 図の数: 42
Buy Now 今すぐ購入

ヨーロッパのウイルスベクター精製市場、製品とサービス別（製品とサービス）、タイプ（レトロウイルスベクター、ワクチンウイルス、アデノウイルスベクター、アデノ随伴ウイルスベクター、レンチウイルス、その他）、ワークフロー（上流処理と下流処理）、精製技術（密度勾配超遠心分離、限外濾過、沈殿、2相抽出システム、クロマトグラフィー）、運用規模（前臨床/臨床および商業）、送達方法（生体内および生体外）、疾患の兆候（がん、遺伝性疾患、感染症、獣医疾患、その他）、アプリケーション（アンチセンスおよびRNAi、遺伝子治療、細胞治療、ワクチン学）、エンドユーザー（バイオテクノロジー企業、製薬会社、研究契約機関、開発製造受託機関（CDMO）、学術/研究機関）、国（英国、ドイツ、フランス、スペイン、イタリア、オランダ、スイス、ロシア、ベルギー、トルコ、その他のヨーロッパ）業界2028年までのトレンドと予測 

欧州のウイルスベクター精製市場市場分析と洞察：ヨーロッパのウイルスベクター精製市場

ウイルスベクター精製市場は、2021年から2028年の予測期間に市場成長を遂げると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に14.5％のCAGRで成長し、2028年までに3億6,736万米ドルに達すると分析しています。ウイルスベクターの需要の高まりは、ウイルスベクター精製市場の原動力となっています。

分子生物学者は、遺伝物質を細胞に送達するためにウイルスベクターを頻繁に使用します。この手順は、生体内（生体内）または細胞培養内（試験管内）で実行できます。ウイルスは、感染した細胞内にゲノムを効率的に輸送するための特殊な分子メカニズムを開発しました。形質導入は、ベクターによる遺伝子またはその他の遺伝物質の送達であり、感染した細胞は形質導入されたと呼ばれます。

COVID-19の出現とウイルスワクチンの需要により、ウイルスベクター精製市場が拡大しています。スケーラビリティの欠如は、ウイルスベクター精製市場の制約となっています。感染症の増加は、ウイルスベクター精製市場にとってチャンスとなっています。熟練した人材の不足は、ウイルスベクター精製市場の課題となっています。

ウイルスベクター精製市場レポートでは、市場シェア、新開発、製品パイプライン分析、国内および現地の市場プレーヤーの影響の詳細、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点から見た機会の分析が提供されます。分析とウイルスベクター精製市場のシナリオを理解するには、アナリスト概要について Data Bridge Market Research にお問い合わせください。当社のチームが、希望する目標を達成するための収益影響ソリューションの作成をお手伝いします。

欧州のウイルスベクター精製市場ウイルスベクター精製市場の範囲と市場規模

ウイルスベクター精製市場は、製品とサービス、タイプ、ワークフロー、精製技術、運用規模、提供方法、疾患の兆候、アプリケーション、およびエンドユーザーに基づいて、9 つの主要なセグメントに分類されます。セグメント間の成長は、ニッチな成長分野と市場にアプローチするための戦略を分析し、コアアプリケーション領域とターゲット市場の違いを決定するのに役立ちます。

  • 製品とサービスに基づいて、ウイルスベクター精製市場は製品とサービスに分類されます。2021年には、ベクター精製のためのさまざまな革新的なソリューションが利用可能になったため、製品セグメントがウイルスベクター精製市場を支配すると予想されます。
  • タイプに基づいて、ウイルスベクター精製市場は、レトロウイルスベクター、ワクチンウイルス、アデノウイルスベクター、アデノ随伴ウイルスベクター、レンチウイルス、その他に分類されます。 2021年には、AAVの感染性の範囲が広いため、アデノ随伴ウイルスベクターセグメントがウイルスベクター精製市場を支配すると予想されます。
  • ワークフローに基づいて、ウイルスベクター精製市場は上流処理と下流処理に分割されます。2021 年には、上流処理セグメントがウイルスベクター精製市場を支配すると予想されます。これは、このプロセスを使用して生成されたウイルスベクターが、トランスフェクション後の短い時間枠で細胞から収穫できるためです。
  • 精製技術に基づいて、ウイルスベクター精製市場は、密度勾配超遠心分離、限外濾過、沈殿、二相抽出システム、クロマトグラフィーに分類されます。2021年には、クロマトグラフィーセグメントがワクチンや遺伝子治療ベクターの精製に広く使用されているため、ウイルスベクター精製市場を支配すると予想されます。
  • 事業規模に基づいて、ウイルスベクター精製市場は前臨床/臨床と商業に分類されます。2021年には、主要な医療機関による研究開発活動への投資の増加により、前臨床/臨床セグメントがウイルスベクター精製市場を支配すると予想されます。
  • 送達方法に基づいて、ウイルスベクター精製市場は、in vivo と ex vivo に分割されます。2021 年には、その高い可用性とプロセスの信頼性により、in vivo セグメントがウイルスベクター精製市場を支配すると予想されます。
  • 病気の兆候に基づいて、ウイルスベクター精製市場は、がん、遺伝性疾患、感染症、獣医疾患、その他に分類されます。 2021年には、遺伝性疾患の発生率と有病率の上昇により、遺伝性疾患セグメントがウイルスベクター精製市場を支配すると予想されます。
  • 用途に基づいて、ウイルスベクター精製市場は、アンチセンスおよびRNAi、遺伝子治療、細胞治療、ワクチン学に分類されます。2021年には、医療分野での幅広い用途により、遺伝子治療セグメントがウイルスベクター精製市場を支配すると予想されます。
  • エンドユーザーに基づいて、ウイルスベクター精製市場は、バイオテクノロジー企業、製薬会社、契約研究機関、契約開発製造組織（CDMO）、学術/研究機関に分類されます。2021年には、さまざまなヘルスケア組織や政府機関による研究努力を奨励するためのイニシアチブ活動の増加により、学術/研究機関セグメントがウイルスベクター精製市場を支配すると予想されます。

ヨーロッパのウイルスベクター精製市場の国別分析

ヨーロッパのウイルスベクター精製市場が分析され、市場規模の情報は、上記の国、製品とサービス、タイプ、ワークフロー、精製技術、運用規模、配信方法、疾患の兆候、アプリケーション、およびエンドユーザー別に提供されます。

ヨーロッパのウイルスベクター精製市場レポートで取り上げられている国は、英国、ドイツ、フランス、スペイン、イタリア、オランダ、スイス、ロシア、ベルギー、トルコ、その他のヨーロッパ諸国です。

ヨーロッパは、ハイテクベースの医療インフラとこの地域の医療費の増加により、2021年から2028年の予測期間に大幅な成長率で成長すると予想されています。この地域のウイルスベクター精製産業の進歩により、ドイツがヨーロッパ市場を支配しています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、ヨーロッパ ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、販売チャネルの影響も考慮されます。  

メーカーによる戦略的取り組みが、ウイルスベクター精製市場のプレーヤーに新たな機会を生み出している 

ウイルスベクター精製市場では、各国の成長に関する詳細な市場分析も提供しています。さらに、ヨーロッパ地域のウイルスベクター精製市場プレーヤー間のウイルスベクター精製販売、パートナーシップ、買収、流通契約の成長に関する詳細なデータも提供しています。データは、2010年から2019年までの履歴期間について利用可能です。  

競争環境とウイルスベクター精製市場シェア分析

ウイルスベクター精製市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と広さ、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータポイントは、ウイルスベクター精製市場に関連する会社の焦点にのみ関連しています。

ヨーロッパのウイルスベクター精製市場レポートで取り上げられている主要企業は、Applied Biological Materials Inc.、Creative Biolabs、Bio-Rad Laboratories, Inc.、Sirion-Biotech GmbH、Merck KGaA、Batavia Biosciences BV、Agilent Technologies, Inc.、Addgene、Takara Bio Inc.、Thermo Fisher Scientific Inc.、uniQure NV、BioVision Inc.、Cytiva (Danaher の子会社) などの国内企業です。DBMR のアナリストは、競争上の強みを理解し、各競合他社の競合分析を個別に提供します。

世界中の企業によって多くの契約や協定も開始されており、これもウイルスベクター精製市場の発展を加速させています。  

例えば、  

  • 2021年1月、サーモフィッシャーサイエンティフィック社は、ベルギーのノヴセップ社のウイルスベクター製造事業の買収を完了し、同社の市場のさらなる多様化に貢献すると発表しました。

市場プレーヤーによるコラボレーション、合弁事業、その他の戦略により、ウイルスベクター精製市場における企業の印象が強化され、組織にとっても売上成長を向上させるメリットがもたらされます。  

SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

Sample Image 画像をクリックすると拡大します
  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE viral vector purification market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET application COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Market Overview
    1. drivers
      1. Rising demand for viral vectors
      2. Availability of diverse range of innovative solutions for vector purification
      3. Emergence of COVID-19 and demand for vaccine development
      4. Benefits of Viral vectors for gene therapy
      5. Growing usage of AAV vectors for delivery of siRNA in mammalian cells
    2. Restraints
      1. lack of scalability
      2. Limitations of downstream purification
    3. OPPORTUNITIES
      1. GROWING CANCER BURDEN WORLDWIDE
      2. RISING NUMBER OF INFECTIOUS DISEASES
      3. GROWING GERIATRIC POPULATION
      4. RISING HEALTH CONSCIOUSNESS AND INCREASING SPENDING ON HEALTHCARE
    4. CHALLENGES
      1. BIOLOGICAL CHALLENGES
      2. SHORTAGE OF SKILLED PERSONNEL
  5. EUROPE VIRAL VECTOR PURIFICATION MARKET: REGULATIONS
  6. Europe Viral vector purification market, By product & services
    1. overview
    2. products
      1. Resin
      2. Kit
      3. Reagent
      4. Prepacked Column
      5. Cassette
      6. Capsule
      7. Filter Plate
    3. services
  7. Europe Viral vector purification market, By purification technique
    1. overview
    2. Chromatography
      1. Affinity Chromatography
      2. Ion-Exchange Chromatography
      3. Size-Exclusion Chromatography
      4. Hydrophilic Interaction Chromatography
    3. Density-Gradient Ultracentrifugation
    4. Ultrafiltration
    5. Precipitation
    6. Two-Phase Extraction Systems
  8. Europe Viral vector purification market, By type
    1. overview
    2. Adeno-Associated Viral Vectors
    3. Adenoviral Vectors
      1. Mastadenovirus
      2. Aviadenovirus
      3. Siadenovirus
      4. Atadenovirus
      5. Ichtadenovirus
    4. Lentivirus
    5. Retroviral Vectors
      1. Replication Defective
      2. Replication-Competent
    6. Vaccine Virus
    7. Other
  9. Europe Viral vector purification market, By workflow
    1. overview
    2. Upstream Processing
    3. Downstream Processing
  10. Europe Viral vector purification market, By scale of operation
    1. overview
    2. Preclinical / Clinical
    3. Commercial
  11. Europe Viral vector purification market, By delivery mode
    1. overview
    2. In Vivo
    3. Ex Vivo
  12. Europe Viral vector purification market, By Disease Indication
    1. overview
    2. Genetic Disorders
      1. Thalassemia
      2. Cystic Fibrosis
      3. Tay-Sachs Disease
      4. Sickle Cell Anemia
      5. Others
    3. Infectious Diseases
      1. Measles Virus
      2. Vesicular Stomatitis Virus
      3. Novel Adenoviruses
      4. Cytomegalovirus
      5. Others
    4. Veterinary Disease
    5. CANCER
    6. OTHER
  13. Europe Viral vector purification market, By Application
    1. overview
    2. Gene Therapy
      1. Recombinant Protein Expression
      2. Functional Assays
      3. Protein Characterization
      4. In Vitro Transcription
      5. Others
    3. cell Therapy
    4. Vaccinology
    5. Antisense & RNAi
  14. Europe Viral vector purification market, By end user
    1. overview
    2. Academic/ Research Institutes
    3. Pharmaceutical Companies
    4. Contract Development and Manufacturing Organization (CDMO)
    5. Biotechnology Companies
    6. Contract Research Organizations
  15. EUROPE VIRAL VECTOR PURIFICATION MARKET, BY GEOGRAPHY
    1. Europe
      1. GERMANY
      2. France
      3. U.K.
      4. ITALY
      5. SPAIN
      6. Netherlands
      7. Belgium
      8. Switzerland
      9. Russia
      10. Turkey
      11. Rest of Europe
  16. Europe Viral Vector Purification Market: COMPANY landscape
    1. company share analysis: Europe
  17. COMPANY PROFILE
    1. THERMO FISHER SCIENTIFC INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. Cytiva (A Subsidiary of Danaher)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    3. Merck KGaA
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. Agilent Technologies, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    5. FUJIFILM Diosynth Biotechnologies
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
    6. addgene
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    7. aldevron
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. Applied Biological Materials Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. BIA Separations
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. BIO-RAD LABORATORIES, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    11. BioVision Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    12. Batavia Biosciences B.V.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. Creative Biogene
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    14. Creative Biolabs
      1. COMPANY SNAPSHOT
      2. SERVICE PORTFOLIO
    15. IDT Biologika GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    16. ProBioGen AG
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. Sirion-Biotech GmbH
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    18. TAKARA BIO INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. uniQure N.V.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    20. Waisman Biomanufacturing
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
  18. questionnaire
  19. related reports

表のリスト

TABLE 1 Europe Viral vector purification market, By product & services, 2019-2028 (USD million)

TABLE 2 Europe Products in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 3 Europe Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 4 Europe Services in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 5 Europe Viral vector purification market, By purification technique, 2019-2028 (USD million)

TABLE 6 Europe Chromatography in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 7 Europe Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 8 Europe Density-Gradient Ultracentrifugation in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 9 Europe Ultrafiltration in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 10 Europe Precipitation in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 11 Europe Two-Phase Extraction Systems in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 12 Europe Viral vector purification market, By type, 2019-2028 (USD million)

TABLE 13 Europe Adeno-Associated Viral Vectors in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 14 Europe Adenoviral Vectors in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 15 Europe Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 16 Europe Lentivirus in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 17 Europe Retroviral Vectors in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 18 Europe Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 19 Europe Vaccine Virus in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 20 Europe other in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 21 Europe Viral vector purification market, By workflow, 2019-2028 (USD million)

TABLE 22 Europe Upstream Processing in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 23 Europe Downstream Processing in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 24 Europe Viral vector purification market, By scale of operation, 2019-2028 (USD million)

TABLE 25 Europe Preclinical / Clinical in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 26 Europe Commercial in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 27 Europe Viral vector purification market, By delivery mode, 2019-2028 (USD million)

TABLE 28 Europe In Vivo in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 29 Europe Ex Vivo in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 30 Europe Viral vector purification market, By Disease Indication, 2019-2028 (USD million)

TABLE 31 Europe Genetic Disorders in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 32 Europe Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 33 Europe Infectious Diseases in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 34 Europe Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 35 Europe Veterinary Disease in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 36 Europe Cancer in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 37 Europe Other in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 38 Europe Viral vector purification market, By Application, 2019-2028 (USD million)

TABLE 39 Europe Gene Therapy in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 40 Europe Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 41 Europe Cell Therapy in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 42 Europe Vaccinology in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 43 Europe Antisense & RNAi in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 44 Europe Viral vector purification market, By end user, 2019-2028 (USD million)

TABLE 45 Europe Academic/ Research Institutes in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 46 Europe Pharmaceutical Companies in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 47 Europe Contract Development and Manufacturing Organization (CDMO) in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 48 Europe Biotechnology Companies in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 49 Europe Contract Research Organizations in Viral Vector Purification Market, By Region, 2019-2028 (USD Million)

TABLE 50 EUROPE viral vector purification Market, By COUNTRY, 2021-2028 (USD million)

TABLE 51 EUROPE Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 52 Europe Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 53 Europe Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 54 Europe Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 55 Europe Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 56 Europe Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 57 Europe Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 58 Europe Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 59 Europe Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 60 Europe Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 61 Europe Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 62 Europe Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 63 Europe Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 64 Europe Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 65 Europe Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 66 Europe Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 67 Germany Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 68 Germany Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 69 Germany Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 70 Germany Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 71 Germany Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 72 Germany Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 73 Germany Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 74 Germany Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 75 Germany Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 76 Germany Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 77 Germany Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 78 Germany Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 79 Germany Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 80 Germany Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 81 Germany Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 82 Germany Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 83 France Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 84 France Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 85 France Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 86 France Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 87 France Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 88 France Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 89 France Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 90 France Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 91 France Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 92 France Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 93 France Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 94 France Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 95 France Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 96 France Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 97 France Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 98 France Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 99 U.K. Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 100 U.K. Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 101 U.K. Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 102 U.K. Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 103 U.K. Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 104 U.K. Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 105 U.K. Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 106 U.K. Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 107 U.K. Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 108 U.K. Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 109 U.K. Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 110 U.K. Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 111 U.K. Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 112 U.K. Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 113 U.K. Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 114 U.K. Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 115 Italy Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 116 Italy Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 117 Italy Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 118 Italy Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 119 Italy Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 120 Italy Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 121 Italy Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 122 Italy Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 123 Italy Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 124 Italy Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 125 Italy Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 126 Italy Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 127 Italy Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 128 Italy Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 129 Italy Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 130 Italy Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 131 Spain Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 132 Spain Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 133 Spain Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 134 Spain Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 135 Spain Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 136 Spain Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 137 Spain Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 138 Spain Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 139 Spain Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 140 Spain Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 141 Spain Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 142 Spain Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 143 Spain Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 144 Spain Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 145 Spain Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 146 Spain Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 147 Netherlands Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 148 Netherlands Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 149 Netherlands Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 150 Netherlands Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 151 Netherlands Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 152 Netherlands Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 153 Netherlands Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 154 Netherlands Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 155 Netherlands Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 156 Netherlands Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 157 Netherlands Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 158 Netherlands Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 159 Netherlands Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 160 Netherlands Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 161 Netherlands Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 162 Netherlands Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 163 Belgium Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 164 Belgium Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 165 Belgium Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 166 Belgium Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 167 Belgium Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 168 Belgium Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 169 Belgium Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 170 Belgium Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 171 Belgium Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 172 Belgium Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 173 Belgium Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 174 Belgium Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 175 Belgium Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 176 Belgium Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 177 Belgium Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 178 Belgium Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 179 Switzerland Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 180 Switzerland Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 181 Switzerland Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 182 Switzerland Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 183 Switzerland Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 184 Switzerland Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 185 Switzerland Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 186 Switzerland Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 187 Switzerland Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 188 Switzerland Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 189 Switzerland Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 190 Switzerland Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 191 Switzerland Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 192 Switzerland Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 193 Switzerland Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 194 Switzerland Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 195 Russia Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 196 Russia Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 197 Russia Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 198 Russia Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 199 Russia Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 200 Russia Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 201 Russia Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 202 Russia Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 203 Russia Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 204 Russia Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 205 Russia Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 206 Russia Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 207 Russia Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 208 Russia Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 209 Russia Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 210 Russia Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 211 Turkey Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 212 Turkey Products in Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

TABLE 213 Turkey Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 214 Turkey Chromatography in Viral Vector Purification Market, By Purification Technique, 2019-2028 (USD Million)

TABLE 215 Turkey Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 216 Turkey Retroviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 217 Turkey Adenoviral Vectors in Viral Vector Purification Market, By Type, 2019-2028 (USD Million)

TABLE 218 Turkey Viral Vector Purification Market, By Workflow, 2019-2028 (USD Million)

TABLE 219 Turkey Viral Vector Purification Market, By Scale of Operation, 2019-2028 (USD Million)

TABLE 220 Turkey Viral Vector Purification Market, By Delivery Method, 2019-2028 (USD Million)

TABLE 221 Turkey Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 222 Turkey Genetic Disorders in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 223 Turkey Infectious Diseases in Viral Vector Purification Market, By Disease Indication, 2019-2028 (USD Million)

TABLE 224 Turkey Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 225 Turkey Gene Therapy in Viral Vector Purification Market, By Application, 2019-2028 (USD Million)

TABLE 226 Turkey Viral Vector Purification Market, By End User, 2019-2028 (USD Million)

TABLE 227 Rest of Europe Viral Vector Purification Market, By Product & Services, 2019-2028 (USD Million)

図表一覧

FIGURE 1 Europe VIRAL VECTOR PURIFICATION MARKET: SEGMENTATION

FIGURE 2 EUROPE VIRAL VECTOR PURIFICATION MARKET: DATA TRIANGULATION

FIGURE 3 Europe Viral vector purification market: DROC ANALYSIS

FIGURE 4 Europe Viral vector purification market: Europe VS REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Viral vector purification market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Viral vector purification market: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Viral vector purification market: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE VIRAL VECTOR PURIFICATION MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE VIRAL VECTOR PURIFICATION MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE viral vector purification market: MARKET application COVERAGE GRID

FIGURE 11 Europe Viral vector purification market: SEGMENTATION

FIGURE 12 Availability of diverse range of innovative solutions for vector purification is DRIVing THE Europe Viral vector purification market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 products SEGMENT is expected to account for the largest share of the Europe VIRAL VECTOR PURIFICATION MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGEs OF Europe viral vector purification market

FIGURE 15 Estimated Number of New Cases in MALE AND FEMALE (ALL AGE GROUP) WORLDWIDE in 2018

FIGURE 1 Europe Viral vector purification market: By product & services, 2020

FIGURE 2 Europe Viral vector purification market: By product & services, 2021-2028 (USD Million)

FIGURE 3 Europe Viral vector purification market: By product & services, CAGR (2021-2028)

FIGURE 4 Europe Viral vector purification market: By product & services, LIFELINE CURVE

FIGURE 5 Europe Viral vector purification market: By purification technique, 2020

FIGURE 6 Europe Viral vector purification market: By purification technique, 2021-2028 (USD Million)

FIGURE 7 Europe Viral vector purification market: By purification technique, CAGR (2021-2028)

FIGURE 8 Europe Viral vector purification market: By purification technique, LIFELINE CURVE

FIGURE 9 Europe Viral vector purification market: By type, 2020

FIGURE 10 Europe Viral vector purification market: By type, 2021-2028 (USD Million)

FIGURE 11 Europe Viral vector purification market: By type, CAGR (2021-2028)

FIGURE 12 Europe Viral vector purification market: By type, LIFELINE CURVE

FIGURE 13 Europe Viral vector purification market: By workflow, 2020

FIGURE 14 Europe Viral vector purification market: By workflow, 2021-2028 (USD Million)

FIGURE 15 Europe Viral vector purification market: By workflow, CAGR (2021-2028)

FIGURE 16 Europe Viral vector purification market: By workflow, LIFELINE CURVE

FIGURE 17 Europe Viral vector purification market: By scale of operation, 2020

FIGURE 18 Europe Viral vector purification market: By scale of operation, 2021-2028 (USD Million)

FIGURE 19 Europe Viral vector purification market: By scale of operation, CAGR (2021-2028)

FIGURE 20 Europe Viral vector purification market: By scale of operation, LIFELINE CURVE

FIGURE 21 Europe Viral vector purification market: By delivery mode, 2020

FIGURE 22 Europe Viral vector purification market: By delivery mode, 2021-2028 (USD Million)

FIGURE 23 Europe Viral vector purification market: By delivery mode, CAGR (2021-2028)

FIGURE 24 Europe Viral vector purification market: By delivery mode, LIFELINE CURVE

FIGURE 25 Europe Viral vector purification market: By disease indication, 2020

FIGURE 26 Europe Viral vector purification market: By disease indication, 2021-2028 (USD Million)

FIGURE 27 Europe Viral vector purification market: By disease indication, CAGR (2021-2028)

FIGURE 28 Europe Viral vector purification market: By disease indication, LIFELINE CURVE

FIGURE 29 Europe Viral vector purification market: By Application, 2020

FIGURE 30 Europe Viral vector purification market: By Application, 2021-2028 (USD Million)

FIGURE 31 Europe Viral vector purification market: By Application, CAGR (2021-2028)

FIGURE 32 Europe Viral vector purification market: By Application, LIFELINE CURVE

FIGURE 33 Europe Viral vector purification market: By end user, 2020

FIGURE 34 Europe Viral vector purification market: By end user, 2021-2028 (USD Million)

FIGURE 35 Europe Viral vector purification market: By end user, CAGR (2021-2028)

FIGURE 36 Europe Viral vector purification market: By end user, LIFELINE CURVE

FIGURE 37 Europe viral vector purification MARKET: SNAPSHOT (2020)

FIGURE 38 Europe viral vector purification MARKET: BY COUNTRY (2020)

FIGURE 39 Europe viral vector purification MARKET: BY COUNTRY (2021 & 2028)

FIGURE 40 Europe viral vector purification MARKET: BY COUNTRY (2020 & 2028)

FIGURE 41 Europe viral vector purification MARKET: BY type (2021-2028)

FIGURE 42 Europe Viral Vector Purification market: company share 2020 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The Europe Viral Vector Purification Market is projected to grow at a CAGR of 14.5% during the forecast period by 2028.
The future market value of the Europe Viral Vector Purification Market is expected to reach USD 367.36 million by 2028.
The major players in the Europe Viral Vector Purification Market are Applied Biological Materials Inc., Creative Biolabs, Bio-Rad Laboratories, Inc., Merck KGaA, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., uniQure N.V., etc.
The countries covered in the Europe Viral Vector Purification Market are U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe.
On the basis of application, the Europe Viral Vector Purification Market is segmented into antisense & RNAi, gene therapy, cell therapy and vaccinology.

関連ページを閲覧する

Banner